FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness
OMEGAZEPRIME News
Published on November 9, 2026 • Originally reported by Berkeley Lovelace Jr.. OMEGAZEPRIME provides independent news coverage and analysis for our readers. Stay informed with the latest developments.
The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness.
Published on November 9, 2026 • Originally reported by Berkeley Lovelace Jr.. OMEGAZEPRIME provides independent news coverage and analysis for our readers. Stay informed with the latest developments.
OMEGAZEPRIME News — For more stories and analysis, visit omegazeprime.com